rs769459903
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 6P and 1B. PM1PP3_StrongBS2_Supporting
The NM_002769.5(PRSS1):āc.107C>Gā(p.Pro36Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000205 in 1,461,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.000066 ( 0 hom., cov: 37)
Exomes š: 0.000021 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
PRSS1
NM_002769.5 missense
NM_002769.5 missense
Scores
12
5
1
Clinical Significance
Conservation
PhyloP100: 5.88
Genes affected
PRSS1 (HGNC:9475): (serine protease 1) This gene encodes a trypsinogen, which is a member of the trypsin family of serine proteases. This enzyme is secreted by the pancreas and cleaved to its active form in the small intestine. It is active on peptide linkages involving the carboxyl group of lysine or arginine. Mutations in this gene are associated with hereditary pancreatitis. This gene and several other trypsinogen genes are localized to the T cell receptor beta locus on chromosome 7. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM1
In a chain Alpha-trypsin chain 1 (size 98) in uniprot entity TRY1_HUMAN there are 13 pathogenic changes around while only 1 benign (93%) in NM_002769.5
PP3
MetaRNN computational evidence supports a deleterious effect, 0.971
BS2
High AC in GnomAdExome4 at 30 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRSS1 | NM_002769.5 | c.107C>G | p.Pro36Arg | missense_variant | 2/5 | ENST00000311737.12 | NP_002760.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRSS1 | ENST00000311737.12 | c.107C>G | p.Pro36Arg | missense_variant | 2/5 | 1 | NM_002769.5 | ENSP00000308720 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152218Hom.: 0 Cov.: 37
GnomAD3 genomes
AF:
AC:
10
AN:
152218
Hom.:
Cov.:
37
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000104 AC: 26AN: 251180Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135744
GnomAD3 exomes
AF:
AC:
26
AN:
251180
Hom.:
AF XY:
AC XY:
14
AN XY:
135744
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461664Hom.: 0 Cov.: 85 AF XY: 0.0000220 AC XY: 16AN XY: 727140
GnomAD4 exome
AF:
AC:
30
AN:
1461664
Hom.:
Cov.:
85
AF XY:
AC XY:
16
AN XY:
727140
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000656 AC: 10AN: 152336Hom.: 0 Cov.: 37 AF XY: 0.0000940 AC XY: 7AN XY: 74490
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
10
AN:
152336
Hom.:
Cov.:
37
AF XY:
AC XY:
7
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
12
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary pancreatitis Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 20, 2023 | The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects PRSS1 function (PMID: 23455445). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PRSS1 protein function. ClinVar contains an entry for this variant (Variation ID: 459181). This missense change has been observed in individual(s) with pancreatitis and diabetes (PMID: 16791840, 23951356, 29555771). This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 36 of the PRSS1 protein (p.Pro36Arg). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 22, 2024 | The p.P36R variant (also known as c.107C>G), located in coding exon 2 of the PRSS1 gene, results from a C to G substitution at nucleotide position 107. The proline at codon 36 is replaced by arginine, an amino acid with dissimilar properties. This alteration has been identified in individuals with idiopathic chronic pancreatitis (Masson E et al. PLoS One 2013 Aug;8(8):e73522; Chen JM et al. Eur J Hum Genet 2000 Jul;8(7):473-9) as well as in individuals with diabetes identified from a cohort of adults undergoing whole genome sequencing to determine risk for chronic illness (Perkins BA et al. Proc Natl Acad Sci U S A 2018 04;115(14):3686-3691). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Hereditary pancreatitis;C0268417:Trypsinogen deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
.;.;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
.;.;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.;D
REVEL
Pathogenic
Sift
Pathogenic
D;.;D
Sift4G
Pathogenic
D;D;D
Polyphen
1.0
.;.;D
Vest4
MutPred
Gain of catalytic residue at P36 (P = 0.0223);Gain of catalytic residue at P36 (P = 0.0223);Gain of catalytic residue at P36 (P = 0.0223);
MPC
0.65
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at